Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker USLM
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Timothy W. Byrne President & CEO, Director | USLM United States Lime & Minerals, Inc. | Sale | 40,466 | $118.54 | $4.8M Sale | Form 4 ↗ |
| Nov 10, 2026 | Timothy W. Byrne President & CEO, Director | USLM United States Lime & Minerals, Inc. | Sale | 1,534 | $119.93 | $184.0K Sale | Form 4 ↗ |
| Sep 9, 2026 | Candou Holdings Ltd. 10% owner | USLM United States Lime & Minerals, Inc. | Buy | 20,000 | $110.00 | $2.2M Buy | Form 4 ↗ |
| Sep 9, 2026 | Antoine M. Doumet Director | USLM United States Lime & Minerals, Inc. | Sale | 20,000 | $110.00 | $2.2M Sale | Form 4 ↗ |
| Mar 3, 2026 | Sandra C. Duhe Director | USLM United States Lime & Minerals, Inc. | Sale | 1,277 | $120.45 | $153.8K Sale | Form 4 ↗ |
| Sep 4, 2025 | Timothy W. Byrne President & CEO, Director | USLM United States Lime & Minerals, Inc. | Sale | 596 | $120.76 | $72.0K Sale | Form 4 ↗ |
| Sep 4, 2025 | Timothy W. Byrne President & CEO, Director | USLM United States Lime & Minerals, Inc. | Sale | 11,504 | $119.43 | $1.4M Sale | Form 4 ↗ |
| Sep 3, 2025 | Timothy W. Byrne President & CEO, Director | USLM United States Lime & Minerals, Inc. | Sale | 1,391 | $124.18 | $172.7K Sale | Form 4 ↗ |
| Sep 3, 2025 | Timothy W. Byrne President & CEO, Director | USLM United States Lime & Minerals, Inc. | Sale | 26,034 | $120.88 | $3.1M Sale | Form 4 ↗ |
| Feb 24, 2025 | Sandra C. Duhe Director | USLM United States Lime & Minerals, Inc. | Sale | 3,157 | $94.61 | $298.7K Sale | Form 4 ↗ |
| Nov 20, 2024 | Timothy W. Byrne President & CEO, Director | USLM United States Lime & Minerals, Inc. | Sale | 992 | $141.00 | $139.9K Sale | Form 4 ↗ |
| Nov 20, 2024 | Timothy W. Byrne President & CEO, Director | USLM United States Lime & Minerals, Inc. | Sale | 20,962 | $139.53 | $2.9M Sale | Form 4 ↗ |
| Nov 19, 2024 | Timothy W. Byrne President & CEO, Director | USLM United States Lime & Minerals, Inc. | Sale | 22,261 | $141.73 | $3.2M Sale | Form 4 ↗ |
| Nov 12, 2024 | Nathan O'Neill Vice President | USLM United States Lime & Minerals, Inc. | Sale | 1,750 | $139.73 | $244.5K Sale | Form 4 ↗ |
14 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:29 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances